# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate o...
NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of...
NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its p...